comparemela.com

Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 33,000 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $3.06, for a total transaction of $100,980.00. Following the sale, the insider now directly owns 124,250 shares of the company’s […]

Related Keywords

, Opaleye Management Inc , Exchange Commission , Ikarian Capital , Securities Exchange Commission , Protara Therapeutics Company Profile , Nasdaq , Protara Therapeutics Inc , Protara Therapeutics , Get Free Report , Opaleye Management , Free Report , Protara Therapeutics Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.